Why African Americans may not be participating in clinical trials

Journal of the National Medical Association

Volumn 88, Issue 10, 1996, Pages 630-634

  Harris, Yvonne ^a   Gorelick, Philip B ^a,b   Samuels, Patricia ^a   Bempong, Isaac ^a  

^a Center on Stroke Research ^*

^b Center for Stroke Research   (United States)

Author keywords

African Americans; Clinical trials; Stroke

Indexed keywords

AFRICAN AMERICAN; AGED; ATTITUDE TO HEALTH; BIOMEDICAL AND BEHAVIORAL RESEARCH; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; EMPIRICAL APPROACH; FEMALE; HUMAN; MALE; MIDDLE AGED; PATIENT SELECTION; QUESTIONNAIRE; RESEARCH SUBJECT; REVIEW; RISK FACTOR; TRUST; UNITED STATES;

BIOMEDICAL AND BEHAVIORAL RESEARCH; EMPIRICAL APPROACH;

AFRICAN AMERICANS; AGED; CEREBROVASCULAR DISORDERS; CLINICAL TRIALS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MIDDLE AGED; PATIENT SELECTION; QUESTIONNAIRES; RESEARCH SUBJECTS; RISK FACTORS; TRUST; UNITED STATES;

EID: 0030265581     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Straub NR. African-Americans: their health and the medical system. Pharos. Winter 1994;18-20.
2. Advance report on final mortality statistics; 1991. Monthly Vital Statistics Report. 1993;42:1-61.
3. Gorelick PB, Harris Y. Stroke: an excess burden on African-Americans. Chicago Medicine. 1993;96(13):28-30.
4. Gaines K, Burke G (for the SECORDS Investigators). Ethnic differences in stroke: black-white differences in the United States population. Neuroepidemiology. 1995;14:209-239.
5. Underwood S, Sanders E, Davis M. Determinants of participation in state-of-the-art cancer prevention, early detection/screening and treatment trials among African-Americans. Cancer Nurs. 1993;16:25-33.
6. Svensson C. Representation of American blacks in clinical trials of new drugs. JAMA. 1989;261:263-265.
7. Allen A: The dilemma of women of color in clinical trials. J Am Med Wom Assoc. 1994;49:105-109.
8. Thomas C, Pinto H, Roach M, Vaughn C. Participation in clinical trials: is it state-of- the-art treatment for African Americans and other people of color? J Natl Med Assoc. 1994;86:177-181.
9. Gavaghan H. Clinical trials face lack of minority group volunteers. Nature. 1995;373:178.
10. Blendon RJ, Aiken LH, Freeman HE, Corey CR. Access to medical care for black and white Americans. JAMA. 1989;261:278-282.
11. Council on Ethical and Judicial Affairs. Black-white disparities in health care. JAMA. 1990;263:2344-2346.
12. Pinn V. The pole of the NIH's Office of Research on Women's Health. Acad Med. 1994;69:698-702.
13. Savitt T. The use of blacks for medical experimentation and demonstration in the old South. Journal of Southern History. 1982;28:331-348.
14. Harrel LE: Autopsy in dementing illness: who participates? Alzheimer Dis Assoc Dis. 1993;7:80-87.
15. Gearing M, Mirra SS, Hedren JC, Sumi SM, Hansen LA, Heyman A. The Consortium to Establish A Registry for Alzheimer's Disease (CERAD), X: neuropathology confirmation of the clinical diagnosis of Alzheimer's disease. Neurology. 1995;45:461-466.
16. Garett W. Racism and sexism in medical care. Soc Org Med Care. 1978;267-271.
17. Caplan A, Edgar H, King P. Twenty years later: the legacy of the Tuskegee Syphilis Study. Hastings Cent Rep. 1992;22(6):29-38.
18. Stoy D, Curtis RC, Dameworth KS, Dowdy AA, Hegland J, Levin JA, et al. The successful recruitment of elderly black subjects in a clinical trial: the CRISP experience. J Natl Med Assoc. 1995;87:280-287.
19. Swanson GM, Ward AJ. Recruiting minorities into clinical trials: toward a participant-friendly system. J Natl Cancer Inst. 1995;87:1747-59.